Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12552810 | Crystalline forms of CFTR modulators | 🖼🧊📄§ | 2026-02-17 | 2041-08-12 | 0 | 31 |
| 12551480 | Treatment using EYP001 | 🖼🧊📄§ | 2026-02-17 | 2040-07-17 | 0 | 31 |
| 12551529 | Liquid formulation of a VEGF antagonist | 🖼🧊📄§ | 2026-02-17 | 2043-02-23 | 0 | 31 |
| 12551517 | Probiotics for cognitive and mental health | 🖼🧊📄§ | 2026-02-17 | 2042-09-30 | 0 | 31 |
| 12551521 | Compositions including pine bark extract, berryfruit extract and a source of l-theanine and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2038-11-13 | 0 | 31 |
| 12551468 | Pharmaceutical composition for oral administration, for treatment of liver cancer | 🖼🧊📄§ | 2026-02-17 | 2040-11-25 | 0 | 31 |
| 12551548 | HIV vaccine compositions, methods, and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-06-10 | 0 | 31 |
| 12551551 | Compositions comprising α-factor prepro sequence and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2043-01-05 | 0 | 31 |
| 12552834 | Selective MENA binding peptides | 🖼🧊📄§ | 2026-02-17 | 2042-01-25 | 0 | 31 |
| 12551553 | Methods for manufacturing an adjuvant | 🖼🧊📄§ | 2026-02-17 | 2039-11-27 | 0 | 31 |
| 12551734 | Betacoronavirus mRNA vaccines | 🖼🧊📄§ | 2026-02-17 | 2044-12-23 | 0 | 31 |
| 12551484 | Methods of treatment and/or prevention of major adverse cardiovascular events (MACE) with a combination of a BET bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor | 🖼🧊📄§ | 2026-02-17 | 2040-11-04 | 0 | 31 |
| 12553063 | CAS13 family AAV vectors and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2040-04-10 | 0 | 31 |
| 12552849 | Method of reducing bispecific t cell engager or chimeric antigen receptor t cell mediated cytokine release syndrome using interleukins-4, -10, or a fusion protein thereof | 🖼🧊📄§ | 2026-02-17 | 2044-09-09 | 0 | 31 |
| 12551523 | HIF-1 activator | 🖼🧊📄§ | 2026-02-17 | 2042-10-04 | 0 | 31 |
| 12553041 | Formulations and doses of pegylated uricase | 🖼🧊📄§ | 2026-02-17 | 2040-06-04 | 0 | 31 |
| 12551522 | Herbal compositions and methods for treating and preventing SARS-CoV-2 virus infection | 🖼🧊📄§ | 2026-02-17 | 2042-11-09 | 0 | 31 |
| 12552874 | Antibodies to carbohydrate antigens | 🖼🧊📄§ | 2026-02-17 | 2040-11-25 | 0 | 31 |
| 12551543 | Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof | 🖼🧊📄§ | 2026-02-17 | 2042-03-10 | 0 | 31 |
| 12551475 | Methods and compositions for treating RNA viral infections | 🖼🧊📄§ | 2026-02-17 | 2041-06-01 | 0 | 31 |
| 12552824 | C-mannoside compounds useful for the treatment of urinary tract infections | 🖼🧊📄§ | 2026-02-17 | 2043-04-28 | 0 | 31 |
| 12551518 | Probiotic system and use thereof | 🖼🧊📄§ | 2026-02-17 | 2040-12-11 | 0 | 31 |
| 12551499 | Highly active compounds against COVID-19 | 🖼🧊📄§ | 2026-02-17 | 2043-09-15 | 0 | 31 |
| 12551495 | Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infection | 🖼🧊📄§ | 2026-02-17 | 2041-03-24 | 0 | 31 |
| 12551564 | IRAK degraders and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2040-12-09 | 0 | 31 |
| 12551494 | Pharmaceutical composition for preventing or treating dengue fever | 🖼🧊📄§ | 2026-02-17 | 2042-02-17 | 0 | 31 |
| 12551569 | RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use | 🖼🧊📄§ | 2026-02-17 | 2045-03-30 | 0 | 31 |
| 12552793 | Purine derivative and medical use thereof | 🖼🧊📄§ | 2026-02-17 | 2040-12-30 | 0 | 31 |
| 12552733 | Terpenophenolic compounds and their use | 🖼🧊📄§ | 2026-02-17 | 2041-03-31 | 0 | 31 |
| 12551514 | Combination of non-viable cells of Streptococcus pyogenes and immune checkpoint inhibitor for the treatment of triple negative breast cancer and non-muscle invasive bladder cancer | 🖼🧊📄§ | 2026-02-17 | 2045-07-25 | 0 | 31 |
| 12552754 | Leflutrozole compositions of matter and processes for preparation | 🖼🧊📄§ | 2026-02-17 | 2045-07-23 | 0 | 31 |
| 12551493 | Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same | 🖼🧊📄§ | 2026-02-17 | 2040-10-21 | 0 | 31 |
| 12552736 | Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders | 🖼🧊📄§ | 2026-02-17 | 2042-06-13 | 0 | 31 |
| 12553027 | Generation and cryopreservation of pluripotent stem cell-derived clinical grade corneal endothelial cells | 🖼🧊📄§ | 2026-02-17 | 2039-12-12 | 0 | 31 |
| 12551506 | Differentiation of olfactory mucosa derived mesenchymal stem cells to schwann cells for peripheral nerve repair | 🖼🧊📄§ | 2026-02-17 | 2042-04-25 | 0 | 31 |
| 12551457 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | 🖼🧊📄§ | 2026-02-17 | 2043-05-01 | 0 | 31 |
| 12552873 | Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2040-06-02 | 0 | 31 |
| 12551555 | Compositions and methods for potentiating immune activity | 🖼🧊📄§ | 2026-02-17 | 2042-06-10 | 0 | 31 |
| 12552788 | IMDQ-PEG-CHOL adjuvant and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-10-07 | 0 | 31 |
| 12551488 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-02-17 | 2045-05-15 | 0 | 31 |
| 12552789 | 1H-pyrrolo[2,3-c]pyridine compounds and application thereof | 🖼🧊📄§ | 2026-02-17 | 2041-09-24 | 0 | 31 |
| 12552795 | Pyrrolotriazine derivatives for treating kit-and PDGFRA-mediated diseases | 🖼🧊📄§ | 2026-02-17 | 2040-04-08 | 0 | 31 |
| 12551541 | Albumin bound macromolecule tri-agonist activating GLP 1/GIP/glucagon receptors and methods therefor | 🖼🧊📄§ | 2026-02-17 | 2044-06-25 | 0 | 31 |
| 12552875 | Anti-human Cripto-1 antibody | 🖼🧊📄§ | 2026-02-17 | 2040-11-10 | 0 | 31 |
| 12552807 | PCSK9 inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-02-17 | 2041-12-20 | 0 | 31 |
| 12551489 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-02-17 | 2045-05-29 | 0 | 31 |
| 12552760 | Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof | 🖼🧊📄§ | 2026-02-17 | 2043-04-21 | 0 | 31 |
| 12552871 | Nucleic acids encoding humanized anti-NGF antibodies | 🖼🧊📄§ | 2026-02-17 | 2041-03-12 | 0 | 31 |
| 12551458 | Topical pharmaceutical composition containing phospholipids | 🖼🧊📄§ | 2026-02-17 | 2044-10-28 | 0 | 31 |
| 12551558 | Compositions and methods for promoting hematopoietic cell cytotoxicity | 🖼🧊📄§ | 2026-02-17 | 2040-04-12 | 0 | 31 |